J. Anderson

发表

ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction

Richard P. Lewis, R. Califf, E. Antman, 1996 .

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Richard P. Lewis, R. Califf, E. Antman, 1996, Journal of the American College of Cardiology.

A rapid and accurate method to realign PET scans utilizing image edge information.

J. Anderson, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect.

J. Anderson, F. Yanowitz, M. Anastasiou-Nana, 1987, American heart journal.

An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO).

J. Muhlestein, J. Anderson, M. A. Gomez, 1996, Journal of the American College of Cardiology.

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

M. Whirl‐Carrillo, L. Gong, R. Altman, 2011, Clinical pharmacology and therapeutics.

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis.

E. Aliot, R. Lazzara, W. Jackman, 1988, Progress in cardiovascular diseases.

Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators.

J. Anderson, L. Karagounis, F. Moreno, 1991, The American journal of cardiology.

High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.

R. Crapo, J. Anderson, M. Anastasiou-Nana, 1986, The Canadian journal of cardiology.

Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project.

J S Martin, T. Aufderheide, W. Weaver, 1990, American heart journal.

Pattern-reversal electroretinographic acuity in untreated eyes with subfoveal neovascular membranes.

G. Fish, D. Birch, J. Anderson, 1992, Investigative ophthalmology & visual science.

Apolipoprotein Polymorphisms Fail to Define Risk of Coronary Artery Disease: Results of a Prospective, Angiographically Controlled Study

R. Ward, J. Anderson, L. Karagounis, 1994, Circulation.

Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.

E. Pritchett, A. Waldo, J. Anderson, 1991, Circulation.

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy.

J. Anderson, S. Sorensen, F. Yanowitz, 1985, The American journal of cardiology.

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

M. Brodsky, D. Follmann, H. Duff, 1999, Journal of the American College of Cardiology.

Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic study.

R. Califf, E. Topol, S. Ellis, 1992, Journal of the American College of Cardiology.

TIMI Perfusion Grade 3 but Not Grade 2 Results in Improved Outcome After Thrombolysis for Myocardial Infarction Ventriculographic, Enzymatic, Electrocardiographic Evidence From the TEAM‐3 Study

L. Becker, J. Anderson, S. Sorensen, 1993, Circulation.

Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.

J. Carlquist, T. Bair, S. P. Elmer, 1999, Journal of the American College of Cardiology.

Ventricular tachyarrhythmias in the long QT syndromes.

E. Aliot, R. Lazzara, W. Jackman, 1984, The Medical clinics of North America.

Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy.

D. Renlund, J. Anderson, F. Yanowitz, 1991, Journal of the American College of Cardiology.

Effects of Probucol on Hyperlipidemic Patients with Cardiac Allografts

J. Schroeder, J. Anderson, 1979, Journal of cardiovascular pharmacology.

Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction.

J. Anderson, S. Sorensen, L. Karagounis, 1992, Journal of the American College of Cardiology.

Admission characteristics were weak predictors of 30-day mortality from myocardial infarction in the elderly.

J. Anderson, 1997, Evidence-based cardiovascular medicine.

Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial.

J Abrams, A. Waldo, J. Anderson, 1985, American heart journal.

Acute treatment of atrial fibrillation and flutter.

J. Anderson, Jeffrey L. Anderson, 1996, The American journal of cardiology.

Impact of the Food and Drug Administration approval of flecainide and encainide on coronary artery disease mortality: putting "Deadly Medicine" to the test.

A. Waldo, J. Anderson, C. Pratt, 1997, The American journal of cardiology.

The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease.

B. Horne, J. Carlquist, J. Muhlestein, 2000, Journal of cardiovascular pharmacology.

Hyperadrenergic state following acute withdrawal from clonidine used at supratherapeutic doses

C. Kablitz, J. Anderson, N. Sarlis, 1996, Clinical Autonomic Research.

Does intravenous heparin or time-to-treatment/reperfusion explain differences between GUSTO and ISIS-3 results?

J. Anderson, L. Karagounis, 1994, The American journal of cardiology.

A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction.

P. R. Frederick, F. Datz, J. Anderson, 1983, The New England journal of medicine.

Electrocardiographic and Enzymatic Infarct Size in a Randomised Study of Intracoronary Streptokinase and Intravenous Anisoylated Plasminogen Streptokinase Activator Complex in Acute Myocardial Infarction

J. Anderson, S. Sorensen, R. Menlove, 2012, Drugs.

Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction.

J. Anderson, S. Sorensen, W. Barry, 1988, American heart journal.

Quantitation of lymphocyte subsets by immunofluorescence flow cytometry in idiopathic dilated cardiomyopathy.

J. Carlquist, R. Higashikubo, J. Anderson, 1985, The American journal of cardiology.

HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors.

J. Carlquist, E. Hammond, J. Anderson, 1984, The American journal of cardiology.

Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.

V. Marder, J. Anderson, J. Hearn, 1992, American heart journal.

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.

D. Renlund, J. Anderson, F. Yanowitz, 1990, The American journal of medicine.

Generating Genetic Risk Scores from Intermediate Phenotypes for Use in Association Studies of Clinically Significant Endpoints

N J Camp, B. Horne, N. Camp, 2005, Annals of human genetics.

Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women.

J. Carlquist, T. Bair, J. Muhlestein, 1998, Journal of the American College of Cardiology.

Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis.

T. Pryor, J. Anderson, L. Karagounis, 1991, The American journal of cardiology.

Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry.

D. Cannom, L. Mitchell, H. Greene, 2001, American heart journal.

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.

D. Renlund, J. Anderson, F. Yanowitz, 1991, Circulation.

Clinically silent atrial septal defects with evidence for cerebral embolization.

J. Anderson, S. Teague, U. Thadani, 1986, Annals of internal medicine.

Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold.

J. Anderson, L. Green, H. Rodier, 1983, The American journal of cardiology.

Update of antibiotic trials for secondary prevention of coronary heart disease.

J. Muhlestein, J. Anderson, Jeffrey L. Anderson, 2005, Future cardiology.

Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.

J. Carlquist, T. Bair, S. P. Elmer, 1999, Journal of the American College of Cardiology.

Implementation of a computerized cardiovascular information system in a private hospital setting.

T. Bair, G. Wagner, J. Muhlestein, 1998, American heart journal.

Vitamin D and cardiovascular risk: hype or new hope?

J. Muhlestein, J. Anderson, 2013 .

Variability of thrombolytic coronary reperfusion: An angiographic study of streptokinase and anistreplase

J. Anderson, S. Sorensen, R. Menlove, 1990, Clinical cardiology.

Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States.

J. Anderson, Jeffrey L. Anderson, 1991, American heart journal.

Comparative effects of diltiazem, propranolol, and placebo on exercise performance using radionuclide ventriculography in patients with symptomatic coronary artery disease: results of a double-blind, randomized, crossover study.

P. Christian, F. Datz, A. Taylor, 1984, American heart journal.

HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors.

J. Carlquist, J. Anderson, M. Anastasiou-Nana, 1986, American heart journal.

"Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty.

J. Muhlestein, J. Anderson, L. Karagounis, 1997, Journal of the American College of Cardiology.

Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.

J. Anderson, 1990, The American journal of cardiology.

Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias.

J. Anderson, Jeffrey L. Anderson, 1990, The American journal of cardiology.

Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction.

S. Yusuf, J. Anderson, L. Griffith, 1989, Circulation.

Summary of efficacy and safety of flecainide for supraventricular arrhythmias.

J. Anderson, D. Jolivette, P. Fredell, 1988, The American journal of cardiology.

The new antiarrhythmic drugs. How to put them to the best use.

J. Anderson, 1988, Postgraduate medicine.

SUDDEN CARDIAC DEATH, VENTRICULAR ARRHYTHMIAS, AND ANTI‐ARRHYTHMIC THERAPY: CURRENT TRIALS AND TRIBULATIONS

J. Anderson, 1986 .

Coronary spasm producing coronary thrombosis and myocardial infarction.

G. Vincent, J. Anderson, H. Marshall, 1983, The New England journal of medicine.

Streptokinase thrombolysis for acute myocardial infarction in young adults with normal coronary arteries.

F. Datz, J. Anderson, H. Marshall, 1983, American heart journal.

Standardized full-field electroretinography. Normal values and their variation with age.

D. Birch, J. Anderson, Jane L. Anderson, 1992, Archives of ophthalmology.

Relationship of two apolipoprotein B polymorphisms with serum lipoprotein and lipid levels in African blacks.

C. Bunker, M. Kamboh, J. Anderson, 1997, Human biology.

Thrombolytic therapy on the homefront. Intravenous urokinase in community hospitals.

J. Anderson, T. Wall, S. Mantell, 1989, North Carolina medical journal.

Comparison of Signal‐Averaging Electrocardiographic Systems Using Device Specific Criteria in 104 Normal Subjects

S. Horn, J. Anderson, L. Karagounis, 1994, Pacing and clinical electrophysiology : PACE.

J. Anderson, L. Karagounis, F. Moreno, 1992, American heart journal.

Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.

B. Horne, J. Carlquist, S. P. Elmer, 1998, Journal of the American College of Cardiology.

Electrophysiologic effects of antiarrhythmic drug therapy in the prediction of successful suppression of induced ventricular tachycardia.

J. Anderson, L. Karagounis, J. Osborn, 1995, American heart journal.

Post-myocardial infarction trials: beta blockers, antiarrhythmics, thrombolytics.

J. Anderson, 1996, Controlled clinical trials.

Medical Therapy for Elderly Patients Who Have Had Myocardial Infarction: Too Little to the Late in Life?

J. Anderson, 1996, Annals of Internal Medicine.

Summary of U.S. clinical trials program for evaluation of anistreplase

J. Anderson, 1990, Clinical cardiology.

Optimal thrombolytic therapy: for whom, when, how.

J. Anderson, 1989, Hospital practice.

Using fluorescent lipids in live zebrafish larvae: From imaging whole animal physiology to subcellular lipid trafficking.

J. Anderson, S. Farber, J. Carten, 2016, Methods in cell biology.

Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease

B. Horne, J. Carlquist, R. Pearson, 2000, Circulation.

Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy.

D. Renlund, W. Abraham, J. Anderson, 1995, The American journal of cardiology.

Should complex ventricular arrhythmias in patients with congestive heart failure be treated? A protagonist's viewpoint.

J. Anderson, 1990, The American journal of cardiology.

Testing the efficacy of antiarrhythmic drugs.

J. Mason, J. Anderson, 1986, The New England journal of medicine.

Fractal dimension predicts arrhythmia recurrence in patients being treated for life-threatening ventricular arrhythmias. ESVEM Investigators.

T. Bair, J. Anderson, K. Stein, 1995, Journal of electrocardiology.

Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.

G. Fish, D. Birch, J. Anderson, 1999, Ophthalmology.

Relative efficiency and risk of endomyocardial biopsy: comparisons in heart transplant and nontransplant patients.

J. Anderson, S. Sorensen, M. Anastasiou-Nana, 1989, Catheterization and cardiovascular diagnosis.

Association of lipoprotein lipase gene polymorphisms with coronary artery disease.

J. Carlquist, T. Bair, S. P. Elmer, 1999, Journal of the American College of Cardiology.

Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy.

E. Hammond, J. Anderson, R. Menlove, 1987, American heart journal.

New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group.

P. Reddy, W. Weaver, J. Anderson, 1994, Journal of the American College of Cardiology.

Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.

J. Anderson, U. Thadani, S. Teague, 1987, The American journal of cardiology.

Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.

J. Anderson, S. Teague, U. Thadani, 1986, Annals of internal medicine.

Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.

E. Pritchett, A. Waldo, J. Anderson, 1989, Circulation.

Effect of prophylactic antiarrhythmic therapy on time to implantable cardioverter-defibrillator discharge in patients with ventricular tachyarrhythmias.

J. Anderson, L. Karagounis, J. Osborn, 1994, The American journal of cardiology.

Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia.

J. Anderson, J. R. Lutz, S. Allison, 1983, Journal of the American College of Cardiology.

Oral flecainide acetate for the treatment of ventricular arrhythmias.

B. Pitt, D. Kvam, G. J. Conard, 1981, The New England journal of medicine.

Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide.

J. Anderson, J. Morganroth, G. Gentzkow, 1986, Journal of the American College of Cardiology.

Current clinical perspectives on antiarrhythmic drug therapy.

J. Anderson, 1986, Federation proceedings.

Flecainide: A New Prototype Antiarrhythmic Agent

J. Anderson, J. Nappi, Jeffrey L. Anderson, 1985, Pharmacotherapy.

Antiarrhythmic strategies for the chronic management of supraventricular tachycardias.

E. Pritchett, J. Anderson, 1988, The American journal of cardiology.

The femoral venous approach to endomyocardial biopsy: comparison with internal jugular and transarterial approaches.

J. Anderson, H. Marshall, Jeffrey L. Anderson, 1984, The American journal of cardiology.

Implantable defibrillators are preferable to pharmacologic therapy for patients with ventricular tachyarrhythmias: an antagonist's viewpoint.

J. Anderson, 1996, Progress in cardiovascular diseases.

Bethanidine Sulfate in Paroxysmal Ventricular Tachycardia: Toxicity and Antifibrillatory Actions

J. Anderson, J. Bauman, D. Prechel, 1986, Pharmacotherapy.

Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22.

M. Pericak-Vance, F. Nuttall, J. Vance, 1999, American journal of medical genetics.

Criteria for selection of patients for programmed electrical stimulation.

J. Mason, J. Anderson, 1986, Circulation.

Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.

J. Anderson, 1990, The American journal of cardiology.

S-cone function in patients with retinitis pigmentosa.

W. Swanson, D. Birch, J. Anderson, 1993, Investigative ophthalmology & visual science.

A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.

B. Horne, J. Carlquist, R. Pearson, 2000, Journal of the American College of Cardiology.

Experimental Antifibrillatory Effects of Calcium Channel Blockade with Diltiazem: Comparison with β‐Blockade and Nitroglycerin

J. Anderson, M. Anastasiou-Nana, J. Nanas, 1984, Journal of cardiovascular pharmacology.

Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins.

J. Lalouel, P. Hopkins, R. Ward, 1997, Journal of lipid research.

Evaluation of total artificial heart performance in man.

J. Anderson, L. Joyce, F. Anderson, 1984, The American journal of cardiology.

Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.

J. Anderson, M. A. Gomez, L. Karagounis, 1993, The American journal of cardiology.

An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.

H. White, J. Anderson, C. Baxter-Jones, 1993, Journal of interventional cardiology.

Overview of patency as an end point of thrombolytic therapy.

J. Anderson, 1991, The American journal of cardiology.

Acute Coronary Occlusion and Reperfusion

J. Anderson, S. Sorensen, W. Barry, 2012, Drugs.

Coronary bypass surgery early after thrombolytic therapy for acute myocardial infarction.

R. M. Nelson, P. Clayton, J. Anderson, 1986, The Annals of thoracic surgery.

Long-term follow-up after intracoronary streptokinase for myocardial infarction: a randomized, controlled study.

J. Anderson, B. Bray, F. Yanowitz, 1984, American heart journal.

Reperfusion, patency and reocclusion with anistreplase (APSAC) in acute myocardial infarction.

J. Anderson, 1989, The American journal of cardiology.

Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells.

D. Romberger, S. Rennard, J. Anderson, 1997, The American journal of physiology.

The Hemodynamic Effects of Intravenous Tocainide in Patients with Heart Disease

P. Meffin, R. Winkle, F. Peters, 1978, Circulation.

Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. The TEAM-3 investigators.

J. Anderson, S. Sorensen, L. Karagounis, 1994, The American journal of cardiology.

Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.

J. Mason, J. Anderson, J. Lessem, 1986, Journal of the American College of Cardiology.

Successful treatment by overdrive pacing of recurrent quinidine syncope due to ventricular tachycardia.

J. Mason, J. Anderson, Jeffrey L. Anderson, 1978, The American journal of medicine.

Chlamydia pneumoniae in coronary artery disease.

B. Horne, J. Carlquist, C. Nielson, 2000, Circulation.

Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.

J. Anderson, M. Anastasiou-Nana, J. R. Lutz, 1985, Journal of the American College of Cardiology.

Efficacy of recainam, a new antiarrhythmic drug, for control of ventricular arrhythmias.

J. Anderson, B. Heath, J. Friedman, 1987, The American journal of cardiology.

Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up.

J. Anderson, 1984, The American journal of cardiology.

A proposal for the clinical use of flecainide.

J. Anderson, J. Stewart, B. Crevey, 1984, The American journal of cardiology.

Explaining discrepant mortality results between primary percutaneous transluminal coronary angioplasty and thrombolysis for acute myocardial infarction.

J. Muhlestein, J. Anderson, L. Karagounis, 1996, American Journal of Cardiology.

Long-term experience with sotalol in the treatment of complex ventricular arrhythmias.

J. Anderson, M. Anastasiou-Nana, J. Nanas, 1987, American heart journal.

Familial automaticity-conduction disorder with associated cardiomyopathy.

J. Anderson, J. R. Lutz, A. Hagan, 1986, The Western journal of medicine.

Response to Encainide of Refractory Ventricular Tachycardia: Clinical Application of Assays for Parent Drug and Metabolites

B. Pitt, J. Anderson, J. Stewart, 1982, Journal of Cardiovascular Pharmacology.

The Disposition of Recainam Hydrochloride During and After Intravenous Loading and Maintenance Infusion in Cardiac Patients

D. Capuzzi, J. Anderson, M. Anastasiou-Nana, 1987, Journal of clinical pharmacology.

Identification of distinct carboxyl-terminal domains mediating internalization and down-regulation of the hamster alpha(1B)- adrenergic receptor.

J. Anderson, M. Toews, J. Wang, 2000, Molecular pharmacology.

Recainam, a potent new antiarrhythmic agent: effects on complex ventricular arrhythmias.

J. Anderson, B. Heath, M. Anastasiou-Nana, 1986, Journal of the American College of Cardiology.

Non-Q wave infarction after thrombolytic therapy.

J. Anderson, 1996, Journal of the American College of Cardiology.

Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction.

J. Anderson, L. Karagounis, S. Ipsen, 1990, The American journal of cardiology.

Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-kappaB.

J. Carlquist, J. Anderson, L. Edelman, 1999, The Journal of infectious diseases.

Accelerated rejection of murine cardiac allografts by murine cytomegalovirus-infected recipients. Lack of haplotype specificity.

J. Carlquist, M. Hammond, J. Anderson, 1993, The Journal of clinical investigation.

Cytokines and rejection of mouse cardiac allografts.

J. Carlquist, J. Anderson, J. Shelby, 1996, Transplantation.

ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-eleva

H. Krumholz, M. Radford, P. Ho, 2008, Circulation.

Occurrence of Circulating Heart‐reactive Antibodies in a Population of Cardiac Transplant Recipients: Correlation with Cardiac Rejection and Subsequent Course

D. Harrison, J. Anderson, E. Stinson, 1979, Circulation.

A mutation in the hamster alpha1B-adrenergic receptor that differentiates two steps in the pathway of receptor internalization.

J. Anderson, M. Toews, J. Zheng, 1997, Molecular pharmacology.

Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.

J. Anderson, P. Podrid, 1996, The American journal of cardiology.

Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study.

J. Anderson, J. R. Lutz, J. Nappi, 1984, The American journal of cardiology.

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.

B. Horne, R. Pearson, T. Bair, 2001, The American journal of cardiology.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Epicardial cardioverter-defibrillators do not cause postoperative arrhythmias. The CABG Patch Trial Investigators. Coronary Artery Bypass Graft.

J. Bigger, A. Curtis, J. Dimarco, 1998, The American journal of cardiology.

Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases.

B. Pitt, J. Anderson, K. Popat, 1981, Archives of internal medicine.

Oral and intravenous bretylium disposition

J. Wagner, J. Anderson, B. Lucchesi, 1980, Clinical pharmacology and therapeutics.

Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998.

J. Anderson, James L. Anderson, D. Waller, 2000, Teratology.

Evaluation of suppressor immune regulatory function in idiopathic congestive cardiomyopathy and rheumatic heart disease.

J. Anderson, H. Kawanishi, J. Greenwood, 1981, British heart journal.

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.

D. Baim, T. LeJemtel, J. Anderson, 1987, Journal of the American College of Cardiology.

Clinical use of the total artificial heart.

E. Hammond, J. Anderson, L. Joyce, 1984, The New England journal of medicine.

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.

J. Carlquist, J. Muhlestein, E. Hammond, 1998, Circulation.

Neutrophil dysfunction in diabetes mellitus.

J. Phair, J. Anderson, C. Watanakunakorn, 1975, The Journal of laboratory and clinical medicine.

Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).

D. Ahern, A. Hallstrom, E. Schron, 1990, The American journal of cardiology.

Differences in sodium and D-glucose transport between hamster and rat lungs.

J. Anderson, J. W. White, B. Goodman, 1994, Journal of applied physiology.

Profound Arterial Hypotension in Dogs: Brain Electrical Activity and Organ Integrity

W. K. Dong, J. Anderson, C. Shaw, 1983, Anesthesiology.

Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations.

B. Pitt, J. Anderson, B. Lucchesi, 1980, The American journal of cardiology.

Initial and long-term outpatient experience with lorcainide for suppression of malignant and potentially malignant ventricular arrhythmias.

J. Anderson, M. Anastasiou-Nana, J. R. Lutz, 1985, American heart journal.

A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction.

J. Carlquist, T. Bair, M. Todd, 1997, Journal of the American College of Cardiology.

Duchenne Muscular Dystrophy and Brain Function

J. Morley, J. Anderson, Jennifer L. Anderson, 2012 .

Brain function in Duchenne muscular dystrophy.

J. Morley, J. Anderson, Jennifer L. Anderson, 2002, Brain : a journal of neurology.

Genetic regulation of Dermatophagoides pteronyssinus-specific IgE responsiveness: a genome-wide multipoint linkage analysis in families recruited through 2 asthmatic sibs. Collaborative Study on the Genetics of Asthma (CSGA).

J. Weber, D. Duffy, K. Barnes, 1998, The Journal of allergy and clinical immunology.

Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.

E. Pritchett, A. Waldo, J. Anderson, 1992, American heart journal.

Sotalol: An important new antiarrhythmic.

E. Prystowsky, J. Anderson, Jeffrey L. Anderson, 1999, American Heart Journal.

Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound.

J. Anderson, J. Heinsimer, U. Thadani, 1986, Journal of the American College of Cardiology.

Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles.

J. Carlquist, M. Feolo, R. Ward, 1995, Journal of the American College of Cardiology.

Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy.

J. Carlquist, M. Feolo, R. Ward, 1994, The American journal of cardiology.

HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies.

J. Carlquist, J. Anderson, R. Menlove, 1991, Circulation.

HLA, Autoimmunity, and Rheumatic Heart Disease Apparent or Real Associations?

J. Carlquist, J. Anderson, 1993, Circulation.

Genetic mapping of a novel familial form of infantile hemangioma.

S. Orlow, D. Marchuk, F. Blei, 1999, American journal of medical genetics.

Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

M L Woods, J. Carlquist, J. Muhlestein, 1996, Journal of the American College of Cardiology.

The ACADEMIC study in perspective (Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia).

J. Muhlestein, J. Anderson, 2000, The Journal of infectious diseases.

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.

B. Horne, J. Carlquist, C. Nielson, 1999, Circulation.

Synaptic plasticity in the dy 2J mouse model of laminin α2-deficient congenital muscular dystrophy

J. Morley, J. Anderson, S. Head, 2005, Brain Research.

Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction.

R. Califf, J. Anderson, L. Karagounis, 1996, The American journal of cardiology.

Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences.

B. Horne, H. May, D. Lappé, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.

C. Cannon, W. Rogers, T. Henry, 1994, Journal of the American College of Cardiology.

Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction.

C. Francis, V. Marder, J. Anderson, 1989, The American journal of cardiology.

Dependence of assessment of coronary artery reperfusion during acute myocardial infarction on angiographic criteria and interobserver variability.

J. Anderson, S. Sorensen, W. Barry, 1988, The American journal of cardiology.

Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.

J. Anderson, S. Sorensen, K. Browne, 1988, Journal of the American College of Cardiology.

Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.

J. Anderson, 1987, Journal of the American College of Cardiology.

A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.

J. Anderson, S. Sorensen, F. Yanowitz, 1984, Circulation.

Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.

P. Shah, J. Anderson, S. Sorensen, 1995, The American journal of cardiology.

Quantification of rate of coronary artery disease progression by a new method of angiographic analysis.

J. Anderson, F. Moreno, R. Menlove, 1991, American heart journal.

Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators.

L. Becker, P. Shah, D. Morris, 1992, Journal of the American College of Cardiology.

A comparison of the accuracy and reproducibility of digital three-dimensional coronary artery reconstructions using edge detection or videodensitometry.

D L Parker, J. Muhlestein, D. Parker, 1997, Computers and biomedical research, an international journal.

Massive viral replication and cytopathic effects in early COVID-19 pneumonia

A. Haase, M. Corbellino, T. Schacker, 2020, 2005.00004.

Multivariate associates of QT dispersion in patients with acute myocardial infarction: primacy of patency status of the infarct-related artery. TEAM-3 Investigators. Third trial of Thrombolysis with Eminase in Acute Myocardial Infarction.

J. Anderson, S. Sorensen, L. Karagounis, 1998, American heart journal.

Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease.

B. Horne, J. Carlquist, T. Bair, 2000, Journal of the American College of Cardiology.

Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis.

J M Lalouel, J. Lalouel, R. Ward, 1995, Circulation.

Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators.

Y. Rosenberg, D. Cannom, A. Hallstrom, 1999, Circulation.

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

R L Berg, M Pirmohamed, P. Deloukas, 2010, Clinical pharmacology and therapeutics.

Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone.

J. Anderson, J. R. Lutz, R. Menlove, 1986, American heart journal.

Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction.

H. Kennedy, G. Friday, M. Gheorghiade, 1999, American heart journal.

Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.

H. Duff, H. Greene, J. Anderson, 1995, American heart journal.

Supraventricular tachyarrhythmias: not always so benign.

J. Anderson, 1991, Journal of the American College of Cardiology.

Heart rate changes preceding ventricular ectopy in patients with ventricular tachycardia caused by reentry, triggered activity, and automaticity.

S. Markowitz, B. Lerman, J. Anderson, 1998, American heart journal.

Fractal clustering of ventricular ectopy correlates with sympathetic tone preceding ectopic beats.

B B Lerman, P Kligfield, K M Stein, 1995, Circulation.

Rationale of combination antiarrhythmic drug therapy.

J. Anderson, 1985, Cardiovascular clinics.

Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias.

J. Anderson, M. Anastasiou-Nana, J. Nanas, 1988, Circulation.

Predictive value for future arrhythmic events of fractal dimension, a measure of time clustering of ventricular premature complexes, after myocardial infarction. CAST Investigators. Cardia Arrhythmia Suppression Trial.

K M Stein, J. Anderson, K. Stein, 1997, Journal of the American College of Cardiology.

24th Bethesda conference: Cardiac transplantation. Task Force 2: Donor guidelines.

J. Anderson, M. Bristow, M. Boucek, 1993, Journal of the American College of Cardiology.

Aminoglutethimide therapy in advanced breast cancer.

J. Anderson, G. Phillipou, R. Black, 1981, The Australian and New Zealand journal of surgery.

Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available.

J. Bigger, J. Anderson, J. Morganroth, 1990, The American journal of cardiology.

Signal-averaged electrocardiography

Michael E. Cain, Albert L. Waldo, J. L. Anderson, 1996 .

Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.

E. Pritchett, T. Guarnieri, J. Anderson, 1994, The American journal of cardiology.

Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy.

J. Anderson, M. Anastasiou-Nana, J. Nanas, 1990, Circulation.

Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30‐day outcomes

J. L. Anderson, B. Horne, H. May, 2016, International journal of laboratory hematology.

Why does thrombolysis fail? Breaking through the reperfusion ceiling.

J. Anderson, J L Anderson, 1997, The American journal of cardiology.

Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.

J. Carlquist, E. Hammond, J. Anderson, 1994, Immunology.

Rod visual fields in cone-rod degeneration. Comparisons to retinitis pigmentosa.

D. Birch, J. Anderson, 1990, Investigative ophthalmology & visual science.

Antiarrhythmic and pharmacokinetic evaluation of intravenous recainam in patients with frequent ventricular premature complexes and unsustained ventricular tachycardia.

R. Myerburg, J. Anderson, C. Reddy, 1993, The American journal of cardiology.

Anistreplase (APSAC): A clinical investigator's update

J. L. Anderson, J. Anderson, 1990 .

Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.

S. Saksena, J. Anderson, R. Freedman, 1991, The American journal of cardiology.

Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias

J. Anderson, J. R. Lutz, J. Nappi, 2004, European Journal of Clinical Pharmacology.

Bretylium tosylate: profile of the only available class III antiarrhythmic agent.

J. Anderson, 1985, Clinical therapeutics.

Gene mutations, atrial fibrillation, and the elusive cigar

J. Carlquist, J. Anderson, 2007, Clinical pharmacology and therapeutics.

R. Califf, W. Weaver, L. Hiratzka, 1996, Journal of the American College of Cardiology.

HLA haplotypes in a family with multiple cases of rheumatoid arthritis.

J. Anderson, J. Michalski, C. McCombs, 1982, Journal of Rheumatology.

Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.

J. Ruskin, T. Wenger, M. Akhtar, 1985, American heart journal.

Chronic collateral growth after femoral artery occlusion in the dog.

J. Anderson, M. Conrad, J. Garrett, 1971, Journal of applied physiology.

Long-term intravenous infusion of antiarrhythmic drugs using a totally implanted drug delivery system.

B. Pitt, J. Anderson, B. Lucchesi, 1981, The American journal of cardiology.

Vascular HLA-DR expression correlates with pathologic changes suggestive of ischemia in idiopathic dilated cardiomyopathy.

E. Hammond, J. Anderson, R. Menlove, 1993, Clinical immunology and immunopathology.